SmallCaps
ASX:ZNOMaterialsSpecialty Chemicals

Zoono Group Ltd

Zoono Group Limited is an Australia-based global biotech company that develops, manufactures and distributes a suite of antimicrobial solutions in multiple countries.

$0.048 ⁠$0.008 (14.29%)AUD · Closed
+38.2%52-week return
Day Range
$0.048$0.049
52 Week Range
$0.000$0.175
Volume
26.25K
Avg Volume (10D)
45.84K
Market Cap
$19.50M
The company

The business

What Zoono Group Ltd does

Zoono Group Limited is an Australia-based global biotech company that develops, manufactures and distributes a suite of antimicrobial solutions in multiple countries. The Company produces sprays, wipes and foams suited for skin care, surface sanitizers and mold remediation treatments. Its products are based on the ZOONO molecule, an antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mold. The Company markets its products in various countries, including Australasia, Asia, United States, India, United Kingdom and Europe. Its subsidiaries include Zoono Group Limited (NZ), Zoono Limited, Zoono Holdings Limited (UK), Zoono EU Limited, Zoono (Shanghai) Biotech Co. Limited, Zoono Holdings USA LLC and Zoono South Africa (Pty) Ltd.

Incorporated
AUS
Public since
1988-07-21
Employees
2
Advertisement

Small Caps Research

Independent ASX small-cap coverage

No research on Zoono Group Ltd yet

We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise ZNO based on demand.

Share price & key data

Share price

OHLC · volume · moving averages
$0.048-$0.002 (-4.00%)over 6M
Hi$0.082Lo$0.000
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today
Open
$0.049
Prev Close
$0.056
Day High
$0.049
Day Low
$0.048
52wk High
$0.175
52wk Low
$0.000

Valuation

Multiples
Market Cap
$19.50M
Shares Out
406.21M
Price/Book
5.74

Trading Activity

Volume & book
Volume
26.25K
Value Traded
$1.28K
Bid
$0.048 × 47,863
Ask
$0.053 × 4,266
Avg Vol 10D
45.84K

Performance

Total return
1 Day
-6.00%
5 Day
-6.00%
13 Week
-32.86%
52 Week
+38.24%
YTD
-40.51%
Peers & news

Latest news

From the Small Caps desk
Zoono透露,四月市场繁荣因专利消毒剂需求不断增长
Industrials & Juniors

Zoono透露,四月市场繁荣因专利消毒剂需求不断增长

抗菌洗手液公司Zoono (ASX: ZNO)再一次给投资者留下了深刻的印象,它的企业对企业的销售额在4月份已经超过了1100万新西兰元(1034万澳元) – 因该公司在英国和欧洲的销量增长进一步收益。 总部位于新西兰的Zoono指出,销售数据不包括在线消费者销售。由于“大量需求”,在线销售已在本月最后7天关闭。 此外,Zoono最近在英国和欧洲获得了“一些新的分销协议”,包括英国的Rentokil Initial、Bunzl Health and Hygiene和Atalian Servest。 Zoono还表示,英国西约克郡警方正在使用其洗手液,并已同意再供应14万份50毫升洗手液单位和补充,以支持该国的前线警察。 与此同时,伦敦地铁以及英国和德国的干线列车都在每月使用Zoono的表面消毒剂。 除了英国和欧洲以外,Zoono还向印度、中国和香港的公司销售了200多万新西兰元的产品,在香港有一家分销商为该国机场当局提供Zoono的产品和喷雾服务。 满足日益增长的需求 到4月下旬,Zoono重新开放了其新西兰网上商店,并将消费者订单的包装和运输外包给第三方物流公司。 为了进一步降低消费者运费成本,Zoono计划在澳大利亚开设一个第三方仓库和分销设施。 该公司还在新西兰建立塑料瓶生产能力,以减少对进口的依赖。 Zoono公司表示:“Zoono处于有利地位,可以满足其Z-71微生物屏蔽表面消毒剂和洗手消毒剂产品的持续需求。” Zoono抗菌产品 Zoono的消毒剂是使用其专利抗菌技术开发,是持久的和环境友好的。 在澳大利亚,Zoono获得了医疗用品管理局的批准,可以修改其产品包装,包括声称其Z-71 Microbe Shield表面消毒剂是一种有效的消毒剂,用于硬表面,对抗冠状病毒以及其他细菌和细菌。 经过独立测试,Zoono在2月下旬证实其杀菌剂对冠状病毒的有效性为99.99%。

Looking for charts & signals? See the tab.

◆ FREE MEMBER ACCESS

Unlock the full research library - free.

Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.

Full broker research library
Complete CEO interview archive
IPO calendar and alerts
New research alerts
Mobile notifications
Members-only market wraps
◆ Free account
Start free
No credit card · Takes 30 seconds · 200,000+ members
Unlock free access →
Continue with Google or email through our secure Auth0 signup.